Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
for Atrial Fibrillation (AF)
6 locations incl. Hartford
Sponsor: McMaster University
Sex: All·Age: 18+
Code: NCT06957366·Recruiting